title: Human Cytomegalovirus pTRS1 and pIRS1 Antagonize Protein Kinase R To Facilitate Virus Replication.
abstract: Human cytomegalovirus (HCMV) counteracts host defenses that otherwise act to limit viral protein synthesis. One such defense is the antiviral kinase protein kinase R (PKR), which inactivates the eukaryotic initiation factor 2 (eIF2) translation initiation factor upon binding to viral double-stranded RNAs. Previously, the viral TRS1 and IRS1 proteins were found to antagonize the antiviral kinase PKR outside the context of HCMV infection, and the expression of either pTRS1 or pIRS1 was shown to be necessary for HCMV replication. In this study, we found that expression of either pTRS1 or pIRS1 is necessary to prevent PKR activation during HCMV infection and that antagonism of PKR is critical for efficient viral replication. Consistent with a previous study, we observed decreased overall levels of protein synthesis, reduced viral protein expression, and diminished virus replication in the absence of both pTRS1 and pIRS1. In addition, both PKR and eIF2α were phosphorylated during infection when pTRS1 and pIRS1 were absent. We also found that expression of pTRS1 was both necessary and sufficient to prevent stress granule formation in response to eIF2α phosphorylation. Depletion of PKR prevented eIF2α phosphorylation, rescued HCMV replication and protein synthesis, and reversed the accumulation of stress granules in infected cells. Infection with an HCMV mutant lacking the pTRS1 PKR binding domain resulted in PKR activation, suggesting that pTRS1 inhibits PKR through a direct interaction. Together our results show that antagonism of PKR by HCMV pTRS1 and pIRS1 is critical for viral protein expression and efficient HCMV replication.
  
  
  OBJECTIVE
  To successfully replicate, viruses must counteract host defenses that limit viral protein synthesis. We have identified inhibition of the antiviral kinase PKR by the viral proteins TRS1 and IRS1 and shown that this is a critical step in HCMV replication. Our results suggest that inhibiting pTRS1 and pIRS1 function or restoring PKR activity during infection may be a successful strategy to limit HCMV disease.
authors.affiliation: Department of Microbiology & Immunology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.|Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
authors.forename: Benjamin
authors.initials: B
authors.lastname: Ziehr
authors.affiliation: Department of Microbiology & Immunology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.|Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
authors.forename: Heather A
authors.initials: HA
authors.lastname: Vincent
authors.affiliation: Department of Microbiology & Immunology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA nmoorman@med.unc.edu.|Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
authors.forename: Nathaniel J
authors.initials: NJ
authors.lastname: Moorman
mesh_terms: D001665:Binding Sites; D002460:Cell Line; D003587:Cytomegalovirus / Q000502:physiology*; D006367:HeLa Cells; D006801:Humans; D009154:Mutation; D034741:RNA, Small Interfering; D014764:Viral Proteins / Q000502:physiology*; D014779:Virus Replication; D019892:eIF-2 Kinase / Q000037:antagonists & inhibitors*
chemical_list: D034741:RNA, Small Interfering; C072216:TRS1 protein, Human herpesvirus 5; D014764:Viral Proteins; D019892:eIF-2 Kinase
references.citation: J Virol. 2005 Jul;79(14):8707-15
references.pmid: 15994764
references.citation: J Virol. 1993 Dec;67(12):6979-88
references.pmid: 8230421
references.citation: Proc Natl Acad Sci U S A. 1994 Jun 7;91(12):5247-51
references.pmid: 8202476
references.citation: J Virol. 1995 Dec;69(12):7960-70
references.pmid: 7494309
references.citation: J Virol. 1996 Jan;70(1):383-92
references.pmid: 8523552
references.citation: Mol Cell Biol. 1996 Nov;16(11):6295-302
references.pmid: 8887659
references.citation: Circ Res. 1996 Dec;79(6):1143-52
references.pmid: 8943952
references.citation: J Virol. 1997 Feb;71(2):1485-96
references.pmid: 8995674
references.citation: Proc Natl Acad Sci U S A. 1997 Feb 4;94(3):843-8
references.pmid: 9023344
references.citation: J Virol. 1997 Jun;71(6):4400-8
references.pmid: 9151830
references.citation: Mol Cell Biol. 1998 Apr;18(4):2282-97
references.pmid: 9528799
references.citation: J Virol. 2005 Dec;79(24):15388-97
references.pmid: 16306610
references.citation: Cell Death Differ. 2006 Mar;13(3):393-403
references.pmid: 16397582
references.citation: J Virol. 2006 Oct;80(20):10083-95
references.pmid: 17005686
references.citation: J Virol. 2006 Oct;80(20):10181-90
references.pmid: 17005695
references.citation: J Virol. 2006 Dec;80(23):11817-26
references.pmid: 16987971
references.citation: Trends Biochem Sci. 2008 Mar;33(3):141-50
references.pmid: 18291657
references.citation: Cell Host Microbe. 2008 Apr 17;3(4):253-62
references.pmid: 18407068
references.citation: Curr Protoc Immunol. 2001 May;Chapter 10:Unit 10.17C
references.pmid: 18432682
references.citation: PLoS Pathog. 2008 Jul;4(7):e1000096
references.pmid: 18604270
references.citation: J Virol. 2009 Feb;83(3):1260-70
references.pmid: 19019949
references.citation: J Virol. 2009 Feb;83(4):1790-9
references.pmid: 19073740
references.citation: J Virol. 2009 May;83(9):4112-20
references.pmid: 19211736
references.citation: Mol Cell. 2009 Dec 25;36(6):932-41
references.pmid: 20064460
references.citation: Mol Cell Proteomics. 2010 May;9(5):851-60
references.pmid: 20023299
references.citation: J Gen Virol. 2010 Sep;91(Pt 9):2167-75
references.pmid: 20444996
references.citation: J Gen Virol. 2010 Sep;91(Pt 9):2221-9
references.pmid: 20519457
references.citation: FEBS Lett. 1976 Sep 15;68(1):119-24
references.pmid: 964373
references.citation: Proc Natl Acad Sci U S A. 1976 Sep;73(9):3107-11
references.pmid: 1067606
references.citation: Proc Natl Acad Sci U S A. 1979 Feb;76(2):600-4
references.pmid: 284384
references.citation: J Biol Chem. 1979 Oct 10;254(19):9846-53
references.pmid: 226529
references.citation: J Virol. 2012 Feb;86(3):1802-8
references.pmid: 22114338
references.citation: J Virol. 2012 Mar;86(5):2571-84
references.pmid: 22205736
references.citation: J Virol. 2012 Apr;86(7):3880-9
references.pmid: 22278235
references.citation: Trends Microbiol. 2012 Apr;20(4):175-83
references.pmid: 22405519
references.citation: Adv Nutr. 2012 May;3(3):307-21
references.pmid: 22585904
references.citation: J Virol. 2012 Oct;86(20):11066-77
references.pmid: 22855486
references.citation: PLoS Pathog. 2013;9(4):e1003266
references.pmid: 23592989
references.citation: Virology. 2013 Jul 20;442(1):28-37
references.pmid: 23601785
references.citation: J Virol. 2014 Feb;88(3):1473-83
references.pmid: 24198422
references.citation: J Virol. 2014 Feb;88(4):2312-8
references.pmid: 24257616
references.citation: Annu Rev Biochem. 2014;83:779-812
references.pmid: 24499181
references.citation: Virology. 2014 Jun;458-459:151-61
references.pmid: 24928047
references.citation: Virology. 2015 Jul;481:13-23
references.pmid: 25765003
references.citation: Proteomics. 2015 Jun;15(12):1983-94
references.pmid: 25894605
references.citation: Autophagy. 2016;12(2):327-42
references.pmid: 26654401
references.citation: Cell Host Microbe. 2008 Apr 17;3(4):206-12
references.pmid: 18407064
references.citation: Ann N Y Acad Sci. 2000;899:363-74
references.pmid: 10863553
references.citation: Virology. 2001 Oct 25;289(2):378-87
references.pmid: 11689059
references.citation: Sci STKE. 2001 Jul 3;2001(89):re2
references.pmid: 11752661
references.citation: J Virol. 2002 May;76(10):4912-8
references.pmid: 11967308
references.citation: J Virol. 2002 Dec;76(23):12290-9
references.pmid: 12414969
references.citation: J Cell Biol. 2003 Mar 17;160(6):823-31
references.pmid: 12642610
references.citation: Proc Natl Acad Sci U S A. 2003 Jun 10;100(12):6974-9
references.pmid: 12777633
references.citation: J Biomed Sci. 2003 Sep-Oct;10(5):505-9
references.pmid: 12928590
references.citation: J Virol. 2003 Oct;77(19):10594-605
references.pmid: 12970444
references.citation: Proc Natl Acad Sci U S A. 2003 Oct 14;100(21):12396-401
references.pmid: 14519856
references.citation: J Virol. 2004 Jan;78(1):197-205
references.pmid: 14671101
references.citation: J Virol. 2004 Oct;78(19):10221-9
references.pmid: 15367587
references.citation: EMBO J. 1987 Mar;6(3):689-97
references.pmid: 3582371
references.citation: J Virol. 1989 May;63(5):2244-51
references.pmid: 2539516
references.citation: J Virol. 1993 May;67(5):2575-82
references.pmid: 8386266
references.citation: J Biol Chem. 2005 Apr 29;280(17):16925-33
references.pmid: 15684421
references.citation: J Virol. 2005 Jun;79(11):6890-9
references.pmid: 15890928
references.citation: J Virol. 2005 Jun;79(12):7311-8
references.pmid: 15919885